StemCells Incorporated

Type: Company
Name: StemCells Incorporated
First reported Aug 26 2014 - Updated Aug 27 2014 - 1 reports

StemCells Q2 net loss increases

StemCells, Inc., a developer of cell-based therapeutics, has reported that net loss for the second quarter ended June 30, 2014 was $12.11 million, or $0.22 loss per share, compared to a net loss of $5.87 million, or $0.15 loss per share, for the same ... [Published Individual.com - Aug 26 2014]
First reported Aug 15 2014 - Updated Aug 15 2014 - 1 reports

Video: Stemcells’ Promising News on Spinal Cord Injury, AMD Therapies

Martin McGlynn, CEO of Stemcells Inc., disclosed to BioWorld fascinating data from a phase I /II clinical trial of human neural stem cells to treat chronic spinal cord injury, including multi-segmental gains in function and a return of function in the ... [Published BioPortfolio - Aug 15 2014]
First reported Aug 15 2014 - Updated Aug 15 2014 - 2 reports

StemCells Inc ShortTerm Noise Creates Another Buying Opportunity

By JMY Investments :I dialed into the StemCells, Inc's (NASDAQ: STEM ) quarterly conference call expecting to hear from a company on its heels from recent allegations of covering up shoddy manufacturing practices by a former employee who is suing the ... [Published BioPortfolio - Aug 15 2014]
First reported Aug 12 2014 - Updated Aug 13 2014 - 3 reports

StemCells' (STEM) CEO Martin McGlynn on Q2 2014 Results - Earnings Call Transcript

OperatorGood day ladies and gentleman and welcome to the StemCells’ Second Quarter 2014 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will be given ... [Published Seeking Alpha - Aug 13 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

Stemcells (STEM) Releases Quarterly Earnings Results

Stemcells (NASDAQ:STEM) issued its quarterly earnings data on Tuesday. The company reported ($0.22) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.14) by $0.08, reports. A number of research firms have recently commented ... [Published American Banking News - Forex - Aug 12 2014]
First reported Aug 11 2014 - Updated Aug 11 2014 - 1 reports

Stemcells (STEM) Scheduled to Post Earnings on Tuesday

Stemcells (NASDAQ:STEM) is scheduled to post its quarterly earnings results on Tuesday, August 12th. Investors interested in registering for the company’s conference call can do so using this link. Stemcells (NASDAQ:STEM) last announced its earnings results ... [Published American Banking News - Forex - Aug 11 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 2 reports

Regenerative Medicine Market in the US 2014-2018: Key Vendors are Baxter, Johnson and Johnson, Kinetic Concepts, Medtronic and Stryker

Dublin, Aug. 6, 2014 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/4rm7h7/regenerative )has announced the addition of the "Regenerative Medicine Market in the US 2014-2018" report to their offering.The Regenerative ... [Published CW Atlanta - Aug 06 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 1 reports

StemCells, Inc. Announces Webcast to Discuss Second Quarter 2014 Financial Results

NEWARK, Calif., Aug. 5, 2014 (GLOBE NEWSWIRE) -- . (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem cell-based research and drug discovery, announced today that it will release ... [Published Wall Street Select - Aug 05 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

StemCells, Inc., and the Quest for a Cure

For the people of StemCells, Inc., one of the most respected stem-cell companies in America, the work they do is more than just a job. They are fighting to ease suffering and save lives. When they use stem cells to challenge spinal-cord injury, it is ... [Published Huffington Post - Jul 29 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Stem cell agency tightens ethics rules

Responding to his predecessor's ethically controversial departure, the president and chief executive of California's stem cell agency said Thursday he is taking legal steps to minimize conflicts of interests with those who have business before the ag ... [Published U-T San Diego - Jul 24 2014]
First reported Jul 11 2014 - Updated Jul 11 2014 - 2 reports

California stem cell agency to review dealings with StemCells Inc.

California’s stem cell agency announced Wednesday it was taking steps to deal with a “risk of conflict of interest” two days after its former president took a position with a company that the state agency had been funding. ... [Published Greenspace - Jul 11 2014]
First reported Jul 08 2014 - Updated Jul 09 2014 - 1 reports

Ex-president of California stem cell agency now on board of StemCells Inc.

StemCells Inc.’s board of directors now includes the former president of the California stem cell agency that gave the company $19.4 million in research funding. StemCells Inc., a Newark company developing stem cell-based therapies, said Monday Dr. Alan ... [Published Tech Chronicles - Jul 08 2014]

Quotes

...The report acknowledged rising auto loan balances, but it concluded that "consumers owe less now than they did during the recession so they can afford to take on more debt." ( http://nyti.ms/1ytJWF1 )
...from our ongoing Phase I II trial in dry age related macular degeneration (AMD)," said Martin McGlynn, president and CEO of StemCellsStemCells Inc. "We reported positive clinical findings, including a 70% reduction in the rate of geographic atrophy, relative to the untreated eye. Geographic atrophy causes vision loss in dry AMD. We also demonstrated an improvement in visual function as measured by the ability to distinguish shades of light versus dark, also referred to as 'contrast sensitivity' in four of the seven patients. These findings are very encouraging and certainly exceeded our expectations."
"We are very excited aboutRexahn Pharmaceuticals Inc.; it's an early-stage oncology company with multiple shots on goal."
...The company is being sued by a former employee, Rob Williams . In his complaint, Williams alleges that he "noted poor sterile technique, failure to adhere to current Good Manufacturing Practices in the company's manufacturing process, and substantial deficiencies in the company's Manual Aseptic Processing of HuCNS-SC (Human Central Nervous System Stem Cells) cell lines...."

More Content

All (66) | News (35) | Reports (0) | Blogs (8) | Audio/Video (0) | Fact Sheets (1) | Press Releases (22)
sort by: Date | Relevance
StemCells Q2 net loss increases [Published Individual.com - Aug 26 2014]
Stem cells: the potential, the reality and the ... [Published Medianet - Aug 25 2014]
Stem Cell Technologies Market by Treatment Mode... [Published Individual.com - Aug 18 2014]
Video: Stemcells’ Promising News on Spinal Cord... [Published BioPortfolio - Aug 15 2014]
StemCells Inc ShortTerm Noise Creates Another B... [Published BioPortfolio - Aug 15 2014]
StemCells, Inc: Short-Term Noise Creates Anothe... [Published Seeking Alpha - Aug 15 2014]
Frontrunning: August 13 [Published Zero Hedge - Aug 13 2014]
EPZM For The Long Haul, RVNC Awaits Facelift, E... [Published RTTNews.com - Aug 13 2014]
Pfizer Issues Top-Line Results from Potherpetic... [Published BioMedReports - Aug 13 2014]
StemCells' (STEM) CEO Martin McGlynn on Q2 2014... [Published Seeking Alpha - Aug 13 2014]
STEMCELLS INC - 10-Q - MANAGEMENT'S DISCUSSION ... [Published Wall Street Business Network - Aug 13 2014]
Stemcells (STEM) Releases Quarterly Earnings Re... [Published American Banking News - Forex - Aug 12 2014]
StemCells, Inc. Reports Second Quarter 2014 Fin... [Published Virtual Strategy Magazine - Aug 12 2014]
StemCells, Inc. Reports Second Quarter 2014 Fin... [Published GlobeNewswire: Advertising News - Aug 12 2014]
StemCells, Inc. Reports Second Quarter 2014 Fin... [Published Industrial Info Financials - Aug 12 2014]
Global Age-Related Macular Degeneration (AMD) M... [Published Individual.com - Aug 12 2014]
Stemcells (STEM) Scheduled to Post Earnings on ... [Published American Banking News - Forex - Aug 11 2014]
Regenerative Medicine Market In The US 2014-201... [Published TheStreet.com - Aug 07 2014]
Regenerative Medicine Market in the US 2014-201... [Published CW Atlanta - Aug 06 2014]
US Regenerative Medicine market will grow at 19... [Published Live-PR.com - Aug 06 2014]
StemCells, Inc. Announces Webcast to Discuss Se... [Published Wall Street Select - Aug 05 2014]
Technical Data on Biotech Stocks -- Arrowhead R... [Published Financial Services - Aug 04 2014]
Christopher James Turns a Clinical Eye on Biote... [Published Stockboard Media Inc. - Aug 01 2014]
California Hispanic Chambers of Commerce Weighs... [Published Fox40 KTXL - Jul 29 2014]
StemCells, Inc., and the Quest for a Cure [Published Huffington Post - Jul 29 2014]
California stem cell agency head takes stand on... [Published Greenspace - Jul 26 2014]
West Coast Biotech Roundup: IPOs, Gilead, Sofin... [Published Xconomy - Jul 25 2014]
CIRM Leader Takes Steps To Avoid Conflicts of I... [Published California Healthline - Jul 25 2014]
Stem Cell Therapy Market to grow at a CAGR of 3... [Published MyNewsDesk - Jul 25 2014]
Stem cell agency tightens ethics rules [Published U-T San Diego - Jul 24 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Frontrunning: August 13 [Published Zero Hedge - Aug 13 2014]
Obama says Missouri shooting death tragic, reflection needed ( Reuters ) U.S. Weighs Iraq Rescue Mission to Save Yazidis ( WSJ ) Maliki says Abadi's appointment as Iraqi PM 'has no value' ( Reuters ) Iran Joins U.S. in Backing Replacement for Iraq’s Maliki ...
California stem cell agency head takes stand on... [Published Greenspace - Jul 26 2014]
The California Institute for Regenerative Medicine has continued in damage-control mode since the state agency’s former president, Alan Trounson, joined the board of directors at StemCells Inc. this month, just seven days after leaving the agency. ...
California stem cell agency to review dealings ... [Published Greenspace - Jul 11 2014]
California’s stem cell agency announced Wednesday it was taking steps to deal with a “risk of conflict of interest” two days after its former president took a position with a company that the state agency had been funding. ...
California stem cell agency to review dealings ... [Published Top of the Ticket - Jul 11 2014]
California’s stem cell agency announced Wednesday it was taking steps to deal with a “risk of conflict of interest” two days after its former president took a position with a company that the state agency had been funding. ...
Stem cell agency outlines steps to prevent “pot... [Published Tech Chronicles - Jul 09 2014]
Two days after the ex-president of California’s stem cell agency became a board director at a company that is receiving funding from the agency, the agency said Wednesday it is taking steps to “mitigate a potential conflict of interest.” Earlier this ...
1 2

Press Releases

sort by: Date | Relevance
StemCells, Inc. Reports Second Quarter 2014 Fin... [Published GlobeNewswire: Advertising News - Aug 12 2014]
Technical Data on Biotech Stocks -- Arrowhead R... [Published Financial Services - Aug 04 2014]
StemCells, Inc. Announces Closing of $20 Millio... [Published GlobeNewswire: Acquisitions News - Jul 18 2014]
StemCells, Inc. Announces Proposed $20 Million ... [Published GlobeNewswire: Advertising News - Jul 15 2014]
StemCells, Inc. Appoints Dr. Alan Trounson to B... [Published GlobeNewswire: Advertising News - Jul 07 2014]
1 2 3 4 5
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.